DBL Potassium Dihydrogen Phosphate

DBL Potassium Dihydrogen Phosphate

potassium phosphate




Zuellig Pharma
Concise Prescribing Info
K dihydrogen phosphate
Severe hypophosphataemia (serum levels <0.3 mmol/L) & other degrees of hypophosphataemia when oral therapy is not possible.
Dosage/Direction for Use
Adult Up to 10 mmol phosphate over 12 hr, may be repeated at 12-hr intervals until serum phosphate exceeds 0.3 mmol/L. Childn 0.15-0.33 mmol/kg over 6 hr, may be repeated at 6-hr intervals until serum phosphate exceeds 0.6 mmol/L. Rate of infusion: Not to exceed 0.2 mmol/kg/hr.
Hyperphosphataemia, hypocalcaemia, hyperkalaemia, Addison's disease, urolithiasis. Severe renal impairment.
Special Precautions
Hypoparathyroidism, rhabdomyolysis, osteomalacia, acute pancreatitis & dehydration, rickets; extensive tissue damage eg, severe burns; myotonia congenita, heart disease particularly in digitalised patients. Bone binding sites saturation. Monitor serum Na, K, phosphate & Ca conc & renal function every 12-24 hr during therapy. Chronic renal disease. Not recommended during pregnancy & lactation.
Adverse Reactions
Hypotension, fluid retention, hyperkalaemia, hypernatraemia, hyperphosphataemia, hypocalcaemia or hypomagnesaemia, extraskeletal calcification eg, nephrocalcinosis in childn.
Drug Interactions
Hyperkalaemia w/ ACE inhibitors, digitalis glycosides, K-sparing diuretics, NSAIDs, other K-contaning medicines. Increased risk of Ca deposition in soft tissues w/ Ca-containing medicines. Hyperphosphataemia w/ other phosphate-containing medicines. Increased salicylates serum conc. Incompatibility w/ Ca- or Mg-containing soln.
MIMS Class
ATC Classification
B05XA06 - potassium phosphate, incl. combinations with other potassium salts ; Belongs to the class of electrolyte solutions used in I.V. solutions.
DBL Potassium Dihydrogen Phosphate inj conc 136.1 mg/mL
10 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in